Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs

Journal of Biomolecular Screening

Volumn 12, Issue 3, 2007, Pages 328-340

  Häupl, Thomas ^a   Yahyawi, Mehdi ^a   Lübke, Carsten ^a   Ringe, Jochen ^a   Rohrlach, Thorsten ^a   Burmester, Gerd R ^a   Sittinger, Michael ^a   Kaps, Christian ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TRANSTISSUE TECHNOLOGIES GMBH   (Germany)

Author keywords

Drug screening; Microarray; Rheumatoid arthritis; Synovial fibroblast

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA6 INTEGRIN; ANTIRHEUMATIC AGENT; CAVEOLIN 2; CELL ADHESION MOLECULE; DICLOFENAC; INTERLEUKIN 1BETA; INTERLEUKIN 8; LANTAREL; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RETINOIC ACID; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMOLUMINESCENCE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DONOR; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; ENZYME IMMUNOASSAY; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOREGULATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; STANDARDIZATION; SYNOVIOCYTE; VALIDATION PROCESS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL DEATH; CELL LINE, TRANSFORMED; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOASSAY; INTERLEUKIN-1BETA; INTERLEUKIN-8; METHOTREXATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDNISOLONE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL FLUID;

EID: 34047144393     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057107299261     Document Type: Article

References (43)

1. Gay S., Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993 ; 52: S39 - S47.
2. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 2003 ; 423: 356-361.
3. Mor A., Abramson SB, Pillinger MH: The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005 ; 115: 118-128.
4. Cronstein BN: Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 2005 ; 57: 163-172.
5. Puolakka K., Kautiainen H., Mottonen T., Hannonen P., Korpela M., Hakala M.,, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005 ; 52: 36-41.
6. Zuckner J.: International experience with diclofenac in rheumatoid arthritis. Am J Med 1986 ; 80: 39-42.
7. Waugh J., Perry CM: Anakinra: a review of its use in the management of rheumatoid arthritis. BioDrugs 2005 ; 19: 189-202.
8. Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE: The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 2005 ; 34: 819-836.
9. Devauchelle V., Marion S., Cagnard N., Mistou S., Falgarone G., Breban M.,, et al. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun 2004 ; 5: 597-608.
10. Burmester GR, Haupl T.: Strategies using functional genomics in rheumatic diseases. Autoimmun Rev 2004 ; 3: 541-549.
11. Jarvis JN, Centola M.: Gene-expression profiling: time for clinical application? Lancet 2005 ; 365: 199-200.
12. Tak PP: Analyzing synovial tissue samples: what can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment? J Rheumatol Suppl 2005 ; 72: 25-26.
13. Haas C., Aicher WK, Dinkel A., Peter HH, Eibel H.: Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int 1997 ; 16: 241-247.
14. Parak WJ, Dannohl S., George M., Schuler MK, Schaumburger J., Gaub HE,, et al. Metabolic activation stimulates acid production in synovial fibroblasts. J Rheumatol 2000 ; 27: 2312-2322.
15. Irizarry RA, Bolstad BM, Collin F., Cope LM, Hobbs B., Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003 ; 31: e15.
16. Gubler U., Hoffman BJ: A simple and very efficient method for generating cDNA libraries. Gene 1983 ; 25: 263-269.
17. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003 ; 48: 2132-2145.
18. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E., Breedveld FC, Verweij CL: Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003 ; 4: 187-196.
19. Watanabe N., Ando K., Yoshida S., Inuzuka S., Kobayashi M., Matsui N.,, et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun 2002 ; 294: 1121-1129.
20. Neumann E., Judex M., Kullmann F., Grifka J., Robbins PD, Pap T.,, et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 2002 ; 9: 1508-1519.
21. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG,, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005 ; 52: 430-441.
22. Lories RJ, Derese I., De Bari C., Luyten FP: In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment. Ann Rheum Dis 2003 ; 62: 568-571.
23. LeRoith D., Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 2003 ; 195: 127-137.
24. Lemmey A., Maddison P., Breslin A., Cassar P., Hasso N., McCann R.,, et al. Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. J Rheumatol 2001 ; 28: 29-34.
25. Matsumoto T., Tsurumoto T.: Inappropriate serum levels of IGF-I and IGFBP-3 in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002 ; 41: 352-353.
26. Fernihough JK, Billingham ME, Cwyfan-Hughes S., Holly JM: Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum 1996 ; 39: 1556-1565.
27. Tavera C., Abribat T., Reboul P., Dore S., Brazeau P., Pelletier JP,, et al. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage 1996 ; 4: 263-274.
28. Nakazawa F., Matsuno H., Yudoh K., Katayama R., Sawai T., Uzuki M.,, et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol 2001 ; 28: 1800-1808.
29. Rinaldi N., Barth TF, Weis D., Schwarz-Eywill M., Pezzutto A., Lukoschek M.,, et al. Loss of laminin and of the laminin receptor integrin subunit alpha 6 in situ correlates with cytokine induced down regulation of alpha 6 on fibroblast-like synoviocytes from rheumatoid arthritis. Ann Rheum Dis 1998 ; 57: 559-565.
30. Laan RF, Jansen TL, van Riel PL: Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford) 1999 ; 38: 6-12.
31. Kahle P., Saal JG, Schaudt K., Zacher J., Fritz P., Pawelec G.: Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992 ; 51: 731-734.
32. Ghivizzani SC, Kang R., Georgescu HI, Lechman ER, Jaffurs D., Engle JM,, et al. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 1997 ; 159: 3604-3612.
33. Rioja I., Bush KA, Buckton JB, Dickson MC, Life PF: Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 2004 ; 137: 65-73.
34. Furst DE: Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004 ; 26: 1960-1975.
35. Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H., Ahern MJ,, et al. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res 2001 ; 3: 65-71.
36. Endo H., Akahoshi T., Nishimura A., Tonegawa M., Takagishi K., Kashiwazaki S.,, et al. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clin Exp Immunol 1994 ; 96: 31-35.
37. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM,, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991 ; 147: 2187-2195.
38. Yamauchi Y., Okazaki H., Desaki M., Kohyama T., Kawasaki S., Yamamoto K.,, et al. Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells. Clin Sci (Lond) 2004 ; 106: 619-625.
39. Herman S., Zurgil N., Deutsch M.: Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res 2005 ; 54: 273-280.
40. Johnston A., Gudjonsson JE, Sigmundsdottir H., Ludviksson BR, Valdimarsson H.: The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis but by the suppression of activation and adhesion molecules. Clin Immunol 2005 ; 114: 154-163.
41. van den Berg WB: Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis. J Rheumatol Suppl 1991 ; 27: 122-123.
42. Yamazaki R., Kusunoki N., Matsuzaki T., Hashimoto S., Kawai S.: Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther 2002 ; 302: 18-25.
43. Lopez-Armada MJ, Sanchez-Pernaute O., Largo R., Diez-Ortego I., Palacios I., Egido J.,, et al. Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis 2002 ; 61: 1027-1030.